• All PLX-treated groups showed improvements in survival rates compared to untreated groups
• PLX-R18 cells did not increase leukocyte levels in non-irradiated NHPs, indicating no requirement to determine levels of radiation exposure prior to administration
• Data will inform a pivotal trial that could support marketing authorization under the FDA’s Animal Rule regulatory pathway

[Read more…]